# Blue Marlin Therapeutics, Inc. — Form D

Blue Marlin Therapeutics, Inc. of CHARLOTTESVILLE, VA, a company, filed a Form D exempt-offering notice with the SEC on 2025-10-21. $100K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2025-10-21
- Form: D
- Accession: 0002092364-25-000001
- Industry: Biotechnology
- Exemptions: 06b
- Amount sold: $100K
- Minimum investment: $1
- Investors: 2
- Date of first sale: 2025-10-06
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-561543

## Issuer

- Name: Blue Marlin Therapeutics, Inc.
- CIK: 0002092364
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2025
- Address: 200 GARRETT STREET, CHARLOTTESVILLE, VA, 22902
- Phone: 434-980-8104

## Officers, directors & promoters (2)

| Name | Role | Location |
| --- | --- | --- |
| Paul Manning | Executive Officer | Charlottesville, VA |
| Sean Stalfort | Executive Officer | Charlottesville, VA |

## More

- [CIK 2092364 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2092364&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002092364-25-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.